South Korea to Pump US$1 Bln Into Drug Sector to Brace for FTAs (South Korea)
This article was originally published in PharmAsia News
Executive Summary
South Korea's government plans a 10-year, approximately $1.07 billion investment in its pharmaceutical industry to prepare for global trade rules under a U.S.-South Korea Free Trade Agreement (FTA). Analysts believe South Korea's domestic drug industry will lose around 168.8 billion won annually to tough U.S. competition if FTA rules are implemented. (Click here for more